Microarray Expression Profile and Analysis of Circular RNA Regulatory Network in Pulmonary Thromboembolism

References

• Schembri GP, Miller AE, Smart R. Radiation dosimetry and safety issues in the investigation of pulmonary embolism. Semin Nucl Med. 2010;40:442–454. doi:10.1053/j.semnuclmed.2010.07.007
   PubMed Web of Science ®Google Scholar
• Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589–602. doi:10.7326/0003-4819-140-8-200404200-00005
   PubMed Web of Science ®Google Scholar
• Benincasa G, Marfella R, Della Mura N, Schiano C, Napoli C. Strengths and opportunities of network medicine in cardiovascular diseases. Circ J. 2020;84:144–152. doi:10.1253/circj.CJ-19-0879
   PubMed Web of Science ®Google Scholar
• Sunderland N, Skroblin P, Barwari T, et al. MicroRNA biomarkers and platelet reactivity: the clot thickens. Circ Res. 2017;120:418–435. doi:10.1161/CIRCRESAHA.116.309303
   PubMed Web of Science ®Google Scholar
• Zhao B, Chen Y, Hu S, et al. Systematic analysis of non-coding RNAs involved in the angora rabbit () hair follicle cycle by RNA sequencing. Front Genet. 2019;10:407. doi:10.3389/fgene.2019.00407
   PubMed Web of Science ®Google Scholar
• Wang Y, Mo Y, Gong Z, et al. Circular RNAs in human cancer. Mol Cancer. 2017;16:25. doi:10.1186/s12943-017-0598-7
   PubMed Web of Science ®Google Scholar
• Salzman J, Gawad C, Wang PL, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7:e30733. doi:10.1371/journal.pone.0030733
   PubMed Web of Science ®Google Scholar
• Suzuki H, Tsukahara T. A view of pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci. 2014;15:9331–9342.
   PubMed Web of Science ®Google Scholar
• Benincasa G, Mansueto G, Napol C. Fluid-based assays and precision medicine of cardiovascular diseases: the ‘hope’ for Pandora’s box? J Clin Pathol. 2019:1–15.
   Web of Science ®Google Scholar
• Zhou M-Y, Yang J-M, Xiong X-D. The emerging landscape of circular RNA in cardiovascular diseases. J Mol Cell Cardiol. 2018;122:134–139. doi:10.1016/j.yjmcc.2018.08.012
   PubMed Web of Science ®Google Scholar
• Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol. 2003;5:R1. doi:10.1186/gb-2003-5-1-r1
   PubMed Web of Science ®Google Scholar
• Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146–D52. doi:10.1093/nar/gku1104
   PubMed Web of Science ®Google Scholar
• Garg K, Welsh CH, Feyerabend AJ, et al. Pulmonary embolism: diagnosis with spiral CT and ventilation-perfusion scanning–correlation with pulmonary angiographic results or clinical outcome. Radiology. 1998;208:201–208. doi:10.1148/radiology.208.1.9646814
   PubMed Web of Science ®Google Scholar
• Altesha MA, Ni T, Khan A, et al. Circular RNA in cardiovascular disease. J Cell Physiol. 2019;234:5588–5600. doi:10.1002/jcp.27384
   PubMed Web of Science ®Google Scholar
• Ghosal S, Das S, Sen R, et al. Circ2Traits: a comprehensive database for circular RNA potentially associated with disease and traits. Front Genet. 2013;4:283. doi:10.3389/fgene.2013.00283
   PubMedGoogle Scholar
• Liu L, Wang J, Khanabdali R, et al. Circular RNAs: isolation, characterization and their potential role in diseases. RNA Biol. 2017;14:1715–1721. doi:10.1080/15476286.2017.1367886
   PubMed Web of Science ®Google Scholar
• Miao R, Wang Y, Wan J, et al. Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension. Medicine. 2017;96:e7354. doi:10.1097/MD.0000000000007354
   PubMed Web of Science ®Google Scholar
• Patnaik SK, Yendamuri S, Kannisto E, et al. MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One. 2012;7:e46045. doi:10.1371/journal.pone.0046045
   PubMed Web of Science ®Google Scholar
• Ge C, Wu S, Wang W, et al. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget. 2015;6:10964–10977. doi:10.18632/oncotarget.3696
   PubMed Web of Science ®Google Scholar
• Tao L, Xue D, Shen D, et al. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis. Arch Toxicol. 2018;92:2935–2946. doi:10.1007/s00204-018-2278-9
   PubMed Web of Science ®Google Scholar
• Teng J, Sun F, Yu P-F, et al. Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis. Int J Clin Exp Pathol. 2015;8:7282–7286.
   PubMed Web of Science ®Google Scholar
• Yan Q, Shen C, Qin J, et al. HIV-1 Vpr inhibits kaposi’s sarcoma-associated herpesvirus lytic replication by inducing MicroRNA miR-942-5p and activating NF-κB signaling. J Virol. 2016;90:8739–8753. doi:10.1128/JVI.00797-16
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Z, Li S, et al. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014;273:897–906. doi:10.1148/radiol.14140121
   PubMed Web of Science ®Google Scholar
• Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117:19–25. doi:10.1016/j.amjmed.2004.01.018
   PubMed Web of Science ®Google Scholar
• Timp JF, Braekkan SK, Versteeg HH, et al. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122:1712–1723. doi:10.1182/blood-2013-04-460121
   PubMed Web of Science ®Google Scholar
• Van Es N, Bleker SM, Di Nisio M. Cancer-associated unsuspected pulmonary embolism. Thromb Res. 2014;133:S172–S8. doi:10.1016/S0049-3848(14)50028-X
   PubMed Web of Science ®Google Scholar
• Gonscherowski V, Becker BF, Moroder L, et al. Calpains: a physiological regulator of the endothelial barrier? Am J Physiol Heart Circ Physiol. 2006;290:H2035–H2042. doi:10.1152/ajpheart.00772.2004
   PubMed Web of Science ®Google Scholar
• Bialkowska K, Kulkarni S, Du X, et al. Evidence that beta3 integrin-induced Rac activation involves the calpain-dependent formation of integrin clusters that are distinct from the focal complexes and focal adhesions that form as Rac and RhoA become active. J Cell Biol. 2000;151:685–696. doi:10.1083/jcb.151.3.685
   PubMed Web of Science ®Google Scholar
• Goll DE, Thompson VF, Li H, et al. The calpain system. Physiol Rev. 2003;83:731–801. doi:10.1152/physrev.00029.2002
   PubMed Web of Science ®Google Scholar
• Dong Y, Wu Y, Wu M, et al. Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase. J Cell Mol Med. 2009;13:2899–2910. doi:10.1111/j.1582-4934.2008.00416.x
   PubMed Web of Science ®Google Scholar
• Arthur JS, Elce JS, Hegadorn C, et al. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol. 2000;20:4474–4481. doi:10.1128/MCB.20.12.4474-4481.2000
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Saido TC, Suzuki K, et al. Calpain mediates integrin-induced signaling at a point upstream of Rho family members. J Biol Chem. 1999;274:21265–21275. doi:10.1074/jbc.274.30.21265
   PubMed Web of Science ®Google Scholar
• Liu D, Yan Z, Minshall RD, et al. Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2012;302:L370–L379. doi:10.1152/ajplung.00349.2011
   PubMed Web of Science ®Google Scholar
• Su Y, Block ER. Role of calpain in hypoxic inhibition of nitric oxide synthase activity in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1204–L12. doi:10.1152/ajplung.2000.278.6.L1204
   PubMed Web of Science ®Google Scholar
• Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest. 2002;121:877–905.
   PubMed Web of Science ®Google Scholar
• Ning H, Liu G, Lin G, et al. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med. 2009;6:967–979. doi:10.1111/j.1743-6109.2008.01172.x
   PubMed Web of Science ®Google Scholar
• Zhao D, Guo M, Liu B, et al. Frontline Science: tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE. J Leukoc Biol. 2017;102:1313–1322. doi:10.1189/jlb.3HI0117-005RR
   PubMed Web of Science ®Google Scholar
• Davis MI, Pragani R, Fox JT, et al. Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models. J Biol Chem. 2016;291:24628–24640. doi:10.1074/jbc.M116.738567
   PubMed Web of Science ®Google Scholar
• Roberti A, Rizzolio F, Lucchetti C, et al. Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines. Cell Cycle. 2011;10:127–134. doi:10.4161/cc.10.1.14446
   PubMed Web of Science ®Google Scholar
• Tselios K, Urowitz MB. Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev. 2017;13:206–218. doi:10.2174/1573397113666170704102444
   PubMed Web of Science ®Google Scholar